Last month, RECOVER TLC met at NIH headquarters in Bethesda. The goal was to initiate a drug development strategy for Long COVID clinical trials.

Now, RECOVER TLC has opened the RECOVER-TLC Intervention Information Request Form, where you can make suggestions about which drugs and other interventions to trial!  Anyone can submit a therapeutic for consideration in future RECOVER-TLC trials. Our lived experience provides invaluable insight into what works and what does not, so this is the perfect occasion to use our knowledge to help others. 

#MEAction will submit recommended therapeutics as an organization.  Make your voice heard by filling out our suggestion form here.  #MEAction will do the work of filling in the more complex submission to RECOVER TLC.

Individuals are welcome to submit their suggestions as well! However, some of the questions asked are complex or require in-depth knowledge of the therapeutic, so MEAction is reaching out to the community for your collective wisdom, consolidating your input, and adding our technical expertise to ensure these therapeutic recommendations include the best possible evidence for use in Long COVID and infection-associated chronic illnesses.